BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15132761)

  • 1. REM sleep and cortisol responses to scopolamine during depression and remission in women.
    Rao U; Lin KM; Schramm P; Poland RE
    Int J Neuropsychopharmacol; 2004 Sep; 7(3):265-74. PubMed ID: 15132761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of scopolamine on nocturnal cortisol secretion, sleep architecture, and REM latency in normal volunteers: relation to sleep and cortisol abnormalities in depression.
    Poland RE; Tondo L; Rubin RT; Trelease RB; Lesser IM
    Biol Psychiatry; 1989 Feb; 25(4):403-12. PubMed ID: 2930809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep electroencephalographic abnormalities in adolescent depressives: effects of scopolamine.
    McCracken JT; Poland RE; Lutchmansingh P; Edwards C
    Biol Psychiatry; 1997 Oct; 42(7):577-84. PubMed ID: 9376454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects.
    Poland RE; McCracken JT; Lutchmansingh P; Lesser IM; Tondo L; Edwards C; Boone KB; Lin KM
    Biol Psychiatry; 1997 May; 41(9):929-38. PubMed ID: 9110098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REM sleep in depression is influenced by ethnicity.
    Poland RE; Rao U; Lutchmansingh P; McCracken JT; Lesser IM; Edwards C; Ott GE; Lin KM
    Psychiatry Res; 1999 Nov; 88(2):95-105. PubMed ID: 10622346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal scopolamine alters phasic REM activity in normal young adults.
    Kim EJ; Jeong DU
    Sleep; 1999 Jun; 22(4):515-20. PubMed ID: 10389227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related effects of scopolamine on REM sleep regulation in normal control subjects: relationship to sleep abnormalities in depression.
    Rao U; Lutchmansingh P; Poland RE
    Neuropsychopharmacology; 1999 Dec; 21(6):723-30. PubMed ID: 10633478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroencephalographic sleep and hypothalamic-pituitary-adrenal changes from episode to recovery in depressed adolescents.
    Rao U; Poland RE
    J Child Adolesc Psychopharmacol; 2008 Dec; 18(6):607-13. PubMed ID: 19108665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bupropion-SR on REM sleep: relationship to antidepressant response.
    Ott GE; Rao U; Nuccio I; Lin KM; Poland RE
    Psychopharmacology (Berl); 2002 Dec; 165(1):29-36. PubMed ID: 12474115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate effects of intravenous clomipramine on sleep and sleep-related secretion in depressed patients.
    Kupfer DJ; Pollock BG; Perel JM; Jarrett DB; McEachran AB; Miewald JM
    Psychiatry Res; 1991 Mar; 36(3):279-89. PubMed ID: 2062969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low-dose dexamethasone on sleep EEG patterns, plasma cortisol, and the TSH response to TRH in major depression.
    Poland RE; McCracken JT; Lutchmansingh P; Tondo L
    Pharmacopsychiatry; 1993 May; 26(3):79-83. PubMed ID: 8415898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repeated doses of scopolamine on the electroencephalographic stages of sleep in normal volunteers.
    Sagalés T; Erill S; Domino EF
    Clin Pharmacol Ther; 1975 Dec; 18(6):727-32. PubMed ID: 173490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroencephalographic sleep studies in depressed outpatients treated with interpersonal psychotherapy: II. Longitudinal studies at baseline and recovery.
    Buysse DJ; Kupfer DJ; Frank E; Monk TH; Ritenour A
    Psychiatry Res; 1992 Apr; 42(1):27-40. PubMed ID: 1603879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk markers for depression in adolescents: sleep and HPA measures.
    Rao U; Hammen CL; Poland RE
    Neuropsychopharmacology; 2009 Jul; 34(8):1936-45. PubMed ID: 19262465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scopolamine-induced muscarinic supersensitivity in normal man: changes in sleep.
    Sitaram N; Moore AM; Gillin JC
    Psychiatry Res; 1979 Jul; 1(1):9-16. PubMed ID: 233155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative effects of selective M1 muscarinic antagonists on rapid eye movement sleep.
    Zoltoski RK; Velazquez-Moctezuma J; Shiromani PJ; Gillin JC
    Brain Res; 1993 Apr; 608(2):186-90. PubMed ID: 8495352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group.
    Gillin JC; Sutton L; Ruiz C; Darko D; Golshan S; Risch SC; Janowsky D
    Biol Psychiatry; 1991 Jul; 30(2):157-69. PubMed ID: 1655072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroencephalographic sleep in recently remitted, elderly depressed patients in double-blind placebo-maintenance therapy.
    Lee JH; Reynolds CF; Hoch CC; Buysse DJ; Mazumdar S; George CJ; Kupfer DJ
    Neuropsychopharmacology; 1993 Feb; 8(2):143-50. PubMed ID: 8471126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.